Skip to main content
. 2014 Mar 26;3(1):204. doi: 10.4081/jphr.2014.204

Table 2.

Opioid substitution therapy in selected South-East Asia Region countries: start date, numbers, linkages, compulsory/court mandated, modality.

Country Year first trialled, started OST Key responsible agencies for OST No. OST sites
(2010-2012)
No. receiving OST
(2009-2012)
OST service links with other health services OST service has links with non-health services Compulsory or court mandated treatment exists Modality of OST delivery
Bangladesh 2010 - M ICDDR,B with funding support from UNODC 2 - M 188 Based in govt detox clinic, where several psychiatrists provide support as and when needed. The OST clinic is also linked to ICDDR, B voluntary counseling testing unit No - but plans underway No Government
India 1993 - B 2011 - M MoH, Ministry of Social Justice, Empowerment, & National AIDS Control Office 120 - B
4 - M
7500 - B 350 - M Weak to good links Weak to good links No Government & NGO
Indonesia 2001 - B 2003 - M MoH for methadone. Private practitioners dispense buprenorphine following training Largely unsupervised by Moh 68 - M
? - B
(50 doctors trained in buprenorphine dispensing
2540 - M 3000 B Weak links Weak Links No Government & Private
Maldives 2008 - M Moh 1 - M 57 - M No No No Government
Myanmar 2004 - M Department of Health - medical care 13 - M 1637 - M Weak to good links Weak to good links Yes Government
Nepal 1994 - M Ministry of Home Affairs, UNODC, Hospitals, NGOs (not part of official government programs) 3 - M 386 - M 175 - B Overall weak links but some sites have good links but with constraints Overall weak links but some sites have good links No Government & NGO
Thailand 1979 - M 2007 - B Thanyarak Institute of the Department of Medical Services, under the Ministry of Public Health 147 - M
? - B
1183 - M
? - B
Fully integrated (most OST services attached within health care settings) Weak links Yes Regional drug treatment centers (of the Department of Medical Services) & Govt Hospitals

OST, opioid substitution therapy; B, Buprenorphine; M, Methadone; ICDDR,B, International Centre for Diarrhoeal Disease Research, Bangladesh; MoH, Ministry of Health.